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Abstract: 
The extent of human intestinal absorption (HIA) for a drug is considered to be an important 
pharmacokinetic parameter which must be determined for orally administered drugs. 
Traditional experimental methods relied upon animal testing and are renowned for being time 
consuming, expensive as well as being ethically unfavourable. As a result, developing 
alternative methods to evaluate a drug’s pharmacokinetics is crucial. Micellar liquid 
chromatography (MLC) is considered to be one of these methods that can replace the use of 
animals in prediction of HIA. In this study, the combination of an aminopropyl column with 
the biosurfactant sodium deoxycholate (NaDC) bile salt were used in the experimental 
determination of micelle-water partition coefficients (log Pmw) for a group of compounds. 
Multiple linear regression (MLR) was then used for the prediction of HIA using the 
experimentally determined log Pmw along with other molecular descriptors leading to the 
construction of a model equation of R
2
= 85 % and a prediction power represented by R
2
Pred. 
=72 %. The use of MLC with an aminopropyl column in combination with NaDC was found 
to be a good method for the prediction of human intestinal absorption, providing data for a far 
wider range of compounds compared with previous studies. 
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1.Introduction: 
The use of micelles in HPLC was first introduced by Armstrong and Henry in 1980 (Berthod 
and Garcia-Alvarez-Coque 2000), now more commonly known as micellar liquid 
chromatography (MLC), and was used to enhance retention and selectivity of various solutes 
that would otherwise be inseparable or poorly resolved. MLC is an interesting technique for 
green chemistry as it uses a mobile phase containing 90 % or more water, these micellar 
mobile phases have low toxicity, are non-flammable and do not produce hazardous waste 
(Kanakaiah 2013). Micellar liquid chromatography uses mobile phases containing a 
surfactant (ionic or non-ionic) above its critical micellar concentration (CMC) along with 
columns such as C18 (and to a lesser extent cyanopropyl (CN)) (Kalyankar, Kulkarni et al. 
2014; Rambla-Alegre 2012). In MLC, surfactant monomers incorporated in the mobile phase 
adsorb on the porous RPLC packing altering the various surface properties of the stationary 
phase, such as surface area, polarity, structure, and pore volume which majorly influences 
chromatographic retention. The stationary phase pores are also coated by the surfactant 
molecules, decreasing their volume (Kalyankar, Kulkarni et al. 2014). Different stationary 
phases have different chemical characteristics which influence the elution of different groups 
of compounds where the formation of an aqueous layer over the stationary phase depends on 
the nature and the number of the chemically bonded groups therefore, determining the 
solutes’ partitioning. As a result, the use of a aminopropyl column was attempted in this work 
to help enhance the applicability of chromatography for absorption prediction where higher 
reactivity and polar interactions are important characteristics of amino columns as discussed 
in literature (Rambla-Alegre, Carda-Broch et al. 2009; Gama, da Costa Silva et al. 2012).  
MLC has been applied to a variety of applications including prediction of transdermal 
permeation (Waters, Shahzad et al. 2013) through to oral drug absorption (Escuder-Gilabert, 
Martınez-Pla et al. 2003), blood brain barrier penetration (Escuder-Gilabert, Molero-Monfort 
et al. 2004) and ocular tissue permeability (Martın-Biosca, Molero-Monfort et al. 2003). In 
recent years, studies have also attempted to link chromatographically derived retention 
constants with pharmacokinetic predictors determined in silico and although linear 
relationships have been found (Milošević, Stojanović, Penov-Gaši, Perišić-Janjić, Kaliszan 
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2014), these previously published studies depend upon the reliability of calculated data 
whereas this work attempts to correlate chromatographic data with published experimental 
data.  Solutes injected within an MLC system are classified according to their elution 
behaviour into three categories; binding, antibinding and non-binding. Binding solutes are 
those which bind or associate to micelles, they show decreased retention when the micelle 
concentration is increased. Antibinding solutes display increased retention with an increased 
concentration of micelles. Finally, non-binding solutes do not bind or associate to micelles 
displaying unaltered retention with changing micellar concentration. 
Previous work by the authors of this study presented the application of a cyanopropyl column 
as a stationary phase in an MLC system using a mixture of bile salts to determine human 
intestinal absorption (HIA) (Waters, Shokry et al. 2016; Shokry, Waters et al. 2018). 
However, for this study, an aminopropyl column was investigated as the stationary phase to 
determine the suitability of this alternative column for facilitating prediction of HIA.  
In summary, the work presented in this paper utilises micellar liquid chromatography to 
predict human intestinal absorption with sodium deoxycholate as the mobile phase and an 
aminopropyl column as the stationary phase. Previous studies have successfully utilised a 
system similar to this yet have been restricted by the variety of compounds that can be 
analysed based upon limitations as a consequence of the stationary phase employed. Through 
incorporating an aminopropyl column in to the system it is envisaged that a far wider range of 
compounds will be suitable for analysis thus expanding the potential applicability of the 
technique. 
2. Materials and Methods 
2.1 Materials 
Sodium deoxycholate (NaDC) was used as purchased from Sigma Aldrich, Dorset, UK (97 
%). Analysed compounds using MLC were acetaminophen (99 %, Sigma Aldrich, Dorset, 
UK), acetyl salicylic acid (99 %, Acros organics, Geel, Belgium), caffeine (97 %, Sigma 
Aldrich, Dorset, UK), carbamazepine (99 %, Sigma Aldrich, Dorset, UK), cimetidine (Sigma 
Aldrich, Dorset, UK), diclofenac (98 %, TCI, Zwijndrecht, Europe), fenoprofen (97 %, 
Fluka, Dorset, UK), fluconazole (98 %, Sigma Aldrich, Dorset, UK), flurbiprofen (98 %, 
TCI, Zwijndrecht, Europe), gemfibrozil (98 %, TCI, Zwijndrecht, Europe), ibuprofen (98 %, 
BASF, Cheshire, UK), indomethacin (99 %, Sigma Aldrich, Dorset, UK), ketoprofen (98 %, 
Sigma Aldrich, Dorset, UK), lidocaine (98 %, Sigma Aldrich, Dorset, UK), lornoxicam (>98 
%, TCI,  Zwijndrecht, Europe), meloxicam (98 %, TCI, Zwijndrecht, Europe), naproxen (98 
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%, Sigma Aldrich, Dorset, UK), nicotinic acid (99.5 %, Sigma Aldrich, Dorset, UK), 
phenylbutazone (98.5 %, Sigma Aldrich, Dorset, UK), piroxicam (98 %, Sigma Aldrich, 
Dorset, UK), salicylic acid (99 %, Fisher Scientific, Loughborough, UK),  theophylline (98 
%, TCI, Oxford, UK) and terbutaline (96 %, Sigma Aldrich, Dorset, UK) used as purchased. 
Deionised water was prepared using a Barnstead™ Ultrapure system. 
2.1 Preparation of NaDC solutions used as mobile phase: 
A 20 mM stock solution of NaDC bile salt in water was prepared by transferring an 
accurately weighed amount of NaDC to a 250 mL volumetric flask and completing to the 
mark with deionised water. Accurately measured aliquots were then transferred from the 
stock solution to 50 mL volumetric flasks; solutions were then completed to the final volume 
with deionised water to give NaDC solutions of concentrations within the range of (5-20 
mM). 
2.2 Experimental Procedure 
Micellar liquid chromatography required injection of 20 μL samples of twenty-three 
compounds (0.2 mM) into a Rheodyne injector and pumped with the mobile phase through a 
reversed phase aminopropyl column (APS) (Hypersil 5µm, 15 cm x 4.6mm, Thermo Fisher 
Scientific, MA, USA) using an Agilent1100 Series Binary pump at a flow rate of 1.34 
mL/min. The retention of the solutes within the column was detected using a UV detector 
(Perseptive Biosystems UVIS-205, MA, USA), set at a wavelength appropriate for each drug 
and recorded via Picolog software indicating retention times. The mobile phase was filtered 
through a 0.45 µm Nylon filter and degassed in an ultrasonic bath. The recorded data were 
analysed to obtain retention factors and each sample was repeated in triplicate to ensure that 
reasonable accuracy and precision were achieved using a series of mobile phases of NaDC 
concentrations. A minimum of five concentrations were analysed per drug ranging from 5-20 
mM. All experiments were performed at room temperature. 
2.3 Determination of Dead time (t0) 
The dead time (t0) (time taken by the solvent front to reach the detector) was measured by the 
injection of water in to the system (Pramauro, Minero et al. 1988)  for the appearance of the 
first major perturbation to the baseline. The dead time was calculated from an average of ten 
results. 
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2.4 Calculation of Log Pmw  
From the recorded retention times for each compound and the dead time, retention factors (k) 
were calculated as follows: 
  
                           
         
           Eq. (1) 
The CMC value of NaDC was taken to be 5 mM (Olesen, Westh et al. 2015) and the micellar 
concentration (CM) was then calculated for each NaDC concentration used as follows: 
                                                                           Eq. (2) 
On the basis of a linear relationship between micellar concentration (CM) and (1/k) according 
to the equations described by Arunyanart and Love (1985), the log of the partition coefficient 
(log Pmw) can be determined for each compound by: 
                                          Eq. (3)  
3. Results: 
Prior to this study, the use of NaDC as a mobile phase (with an alternative column) 
confirmed the potential of MLC in the prediction of HIA (Waters, Shokry et al. 2016).  A 
further study considered the effect of changing the mobile phase composition confirming the 
use of a mixture of NaDC along with phospholipid was a better predictive system of HIA 
than NaDC alone (Shokry, Waters et al. 2018). This current study explores the effect of an 
alternative stationary phase regarding HIA predictive capability. 
3.1 Selection of Aminopropyl column 
According to literature, aminopropyl columns are widely used especially in hydrophilic 
interaction liquid chromatography (HILIC). They also offer a more reactive, selective and 
efficient stationary phase and polar interactions are more abundant than in cyanopropyl 
columns (Rambla-Alegre, Carda-Broch et al. 2009; Gama, da Costa Silva et al. 2012). Also 
aminopropyl columns offer the possibility of anion exchange mechanisms around neutral pH 
(Olsen 2001). Compounds such as amines, ethers, esters and ketones are preferentially 
retained on amino columns compared with cyano columns. This could be the reason why 
more compounds were analysed using this column (rather than a cyano column) in the 
previous study. Furthermore, because of general concerns about stability and reproducibility, 
cyanopropyl columns are less commonly used overall.  
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3.2 Effect on retention behaviour 
Experimental data for the calculated log Pmw values, along with published physicochemical 
data utilised for analysis are presented within ‘Supplementary Information’ (Table S1). The 
use of an aminopropyl column as a stationary phase had a great impact on the retention 
profiles for a number of the analysed compounds (including neutral, anionic and cationic 
compounds) using MLC. Therefore, there was an appreciable effect on the obtained log Pmw 
values which is a reflection of the partitioning process of the compounds under study. The 
dead time average value was determined to be 79.40 seconds. 
Ideally, neutral and cationic drugs are expected to show binding behaviour whilst anionic 
drugs are expected to show antibinding behaviour with the increase in the bile salt 
concentration. Interestingly, the opposite to what was expected was observed in that neutral 
compounds displayed antibinding behaviour whilst cationic and anionic drugs displayed both 
binding and antibinding behaviour according to their molecular weight.  
3.2.1 Theory behind retention behaviour 
Salt bridge formation is assumed to be the justification behind the change in the way drugs 
interacted with the stationary phase (aminopropyl column) that led to unconventional patterns 
of elution. This assumption is supported by the work of Takeuchi et al. who presented the 
possibility of using bile acids as stationary phases in liquid chromatography through their 
immobilisation on aminopropyl silica through electrostatic interactions (Takeuchi, Chu et al. 
1998). A salt bridge is a combination of two noncovalent interactions which are hydrogen 
bonding and electrostatic interactions. Although such bridges are abundant in protein folded 
conformations (to provide stability) they are also found in supramolecular chemistry. Since 
the pH of the medium was found to be in the range of (6.4-8.0) the amino group (-NH2) is 
thought to undergo protonation converting to the ammonium ion (-NH3
+
) and, in this case, 
rendering the column positively charged. As a result, a salt bridge is assumed to have formed 
through electrostatic attraction between the negatively charged carboxylic group (–COO-) of 
NaDC and the positively charged ammonium group (-NH3
+
) of the column also, through 
hydrogen bonding between the hydrogen atom of the ammonium group (-NH3
+
) and the 
oxygen atom of the carboxylic group (–COO-) which adds up to the overall stability of the 
formed network as it acts as a small stabilising interaction (Anslyn and Dougherty 2006). The 
charge on both the column and the bile salt adsorbed on its surface are masked by their 
electrostatic attraction. Salt bridges form between the bile salt monomers and the column 
creating a stable network. Also, hydrogen bonds form between the bile salts hydroxyl groups 
as well as the nonpolar binding of the hydrophobic moiety of NaDC molecules, creating a 
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network with free monomers from the mobile phase leading to the formation of the 
appearance of bilayers of bile salt. 
Although some anionic drugs displayed antibinding behaviour (which is typical for 
conventional retention), a number of anionic drugs exhibited the opposite behaviour i.e. a 
binding interaction with NaDC. Both cases can be explained according to the previously 
mentioned theory for bile salt (micellar mobile phase) interactions with the aminopropyl 
column used in this method. 
The anionic drugs (fenoprofen, ibuprofen, gemfibrozil and phenylbutazone) displayed a 
retention behaviour typical for that expected for anionic compounds with anionic surfactant 
with an antibinding interaction with the NaDC micelles. On the other hand, three anionic 
drugs, namely lornoxicam, meloxicam and piroxicam displayed an opposite pattern of 
interaction as they acted as binding solutes. This is unusual for anionic drugs when analysed 
with anionic surfactants in MLC.  
The typical antibinding behaviour of anionic compounds can be attributed to the electrostatic 
repulsion taking place between the negatively charged compounds and the negatively charged 
surfactant. As a result of this repulsion the compound bound to the column displayed an 
increase in retention on the column with the increase in the surfactant concentration. In this 
case the drug must have a low molecular weight in order to be entrapped inside the layers of 
the bile salt network structure formed with the aminopropyl column by means of electrostatic 
attraction and hydrogen bonding. As a result, fenoprofen, ibuprofen, gemfibrozil and 
phenylbutazone, having relatively low molecular weights of 242.3, 206.3, 250.3 and 308.4 
g/mol respectively (http://www.chemspider.com/), were entrapped inside the bile salt 
network structure displaying an antibinding interaction. However, lornoxicam, meloxicam 
and piroxicam, having relatively higher molecular weight values of 371.8, 351.4 and 331.4 
g/mol respectively (http://www.chemspider.com/), could not be entrapped inside the bile salt 
network structure. Instead, they were entrapped inside the micellar core, overcoming the 
repulsion forces with the micelles as a consequence of their high molecular weights (Figure 
1). 
For neutral drugs (acetaminophen, caffeine, fluconazole and theophylline), an antibinding 
retention behaviour was observed which is again, against convention, where neutral drugs 
traditionally undergo a binding interaction. This can be attributed to the preference of these 
drugs to bind to the more stable hydrophobic core of the bile salt network structure rather 
than that of the bile salt micelles in the mobile phase. Also these drugs have comparatively 
low molecular weights of 151.2, 194.2, 306.27, 180.2 g/mol respectively 
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(http://www.chemspider.com/), facilitating entrapment within the hydrophobic core of the 
bile salt network structure within the column therefore showing antibinding retention 
behaviour. 
3.3 Prediction of human intestinal absorption (HIA) 
Statistical data analysis was conducted using Minitab 17
® 
software. Multiple linear regression 
was carried out where different molecular descriptors collected from literature were regressed 
against the dependant variable %HIA and a backward elimination modelling strategy was 
carried out. To take variance inflation factors (VIF) to acceptable limits, variables with high 
(VIF) were removed. Finally, an optimum model was obtained that provides a good summary 
of data, this was undertaken in a similar manner to that previously published (Waters, Shokry 
et al. 2016).    
The variables remaining in the optimal model were assessed for significance and relative 
importance by standardised coefficients and the associated p-values. 
The predictive ability of the final model was assessed using adjusted-R
2
 and R
2
 for prediction 
(R
2
PRED) derived from predicted residual error sum of squares (PRESS statistic). The 
predictive ability of the model was indicated by R
2
PRED which consequently reflects the 
model’s applicability. 
In this study, a group of twenty-three drugs were analysed using the MLC system using an 
aminopropyl (APS) column and log Pmw was calculated for each compound, a number of 
molecular descriptors such as molecular weight (Mwt), polar surface area (PSA), freely 
rotating bonds (FRB), molar volume (VM), dissociation constant (pKa), aqueous solubility 
(Sw), number of hydrogen bond donors (nHD) and number of hydrogen bond acceptors 
(nHA) were used along with the obtained log Pmw to develop a mathematical model for 
prediction of %HIA. 
Logit (%HIA) was used to improve the linear relationship between published (%HIA) and 
experimental log Pmw values as seen in studies of a similar type (Norinder, Österberg et al. 
1999; Raevsky, Fetisov et al. 2000; Zhao, Abraham et al. 2002). The human intestinal 
absorption values were transformed to logit by substitution in Equation 4. 
Logit (%HIA) = log (%HIA / (100-%HIA))                Eq. (4) 
For simplification, all drugs of 100 or 0 % HIA were excluded from the training set. 
Log Pmw was successfully included with 2 other molecular descriptors in the final model 
equation with %HIA experimental values for orally administered drugs which successfully 
predicted the %HIA with 72 % predictability. The final model was validated using a set of 
seven compounds. 
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The model obtained for the prediction of %HIA is given by Equation 5: 
 
logit %HIA = -0.758 – 0.369 log Pmw + 0.01157 VM + 0.0714 Sw         Eq. (5) 
Sixteen drugs were used in the development of the final model. The model’s R2 = 84.62 %,  
R
2
adjust.= 80.77 % , R
2
PRED = 71.51 %, S= 0.203 
A 95 % confidence interval for log Pmw is given by (-0.726, -0.011), t-statistic and 
standardised coefficient of log Pmw are –2.25 (p<0.05) and -0.294 respectively suggesting 
statistical significance of log Pmw as a predictor. Also the F-ratio of the overall model is 
statistically significant, F= 22 and P value 0.000 (p<0.05). Figure 2 shows no marked 
relationship between residuals and predicted values while Figure 3 summarises the model. 
Seven drugs (cimetidine, fenoprofen, lornoxicam, nicotinic acid, piroxicam, salicylic acid and 
terbutaline) were used to test the model predictability. The model was able to predict the 
%HIA for these drugs within a minimum of 0.1 % and a maximum of 8 % difference between 
the predicted %HIA and the published %HIA. The model appears to have underestimated 
%HIA for both lornoxicam and salicylic acid with a 12 % and 24 % difference between the 
two predicted and published values. The relationship between the predicted and the 
experimental %HIA values is shown in Table 1 and Figure 4. 
Comparing this current model with that obtained with the MLC system using a cyanopropyl 
column; logit HIA = -0.410 - 0.482 log Pmw + 0.00852 Mwt + 0.04799 Sw (Waters, Shokry et 
al. 2016), it is observed that three predictors were included in each model: (log Pmw and Sw) 
in both models, Mwt (in CN column derived model) and VM (in APS column derived model). 
According to literature, molecular weight (Mwt) and molar volume (VM) are both estimates 
of size however, VM takes into consideration both the size and shape as it is very much 
related to molecular surface area which offers a better guide to estimate the potential for 
permeability (Smith, Walker et al. 2006). Although both models have nearly the same HIA 
prediction ability, this current model was obtained based on a larger data set where the 
change of the used column from CN to APS allowed the analysis of a larger number of 
compounds. This is because the latter column resulted in compound-stationary phase 
interactions that facilitated calculation of values for compounds that had been unsuccessfully 
analysed using the former column type.  
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Finally, combining the results of changing the column type from CN to APS and changing 
the type of micellar mobile phase from NaDC to a physiological mixture of bile salts with 
lecithin, it is hypothesised that the use of an MLC system that combines the use of an APS 
column with bile salts with lecithin as a mobile phase would provide a more reliable HIA 
predictive model covering a wider range of %HIA prediction. 
 
4. Conclusion: 
The change in the type of the stationary phase used in the MLC method from cyanopropyl to 
aminopropyl (APS) had a significant impact on the interaction of the analysed drugs with 
both the micellar mobile phase and the stationary phase used and consequently on their 
elution. This method was able to predict %HIA using a reliable model. This MLC method has 
one major advantage over that previously published with a different column in that it permits 
analysis of a greater number of compounds than that analysed prior to this study. This is 
because some compounds displayed non-binding behaviour in the previously published 
method (i.e. it was not possible to calculate log Pmw for these compounds) yet they displayed 
binding or antibinding behaviour using this method. This expanded study helps in the 
establishment of a reliable model for prediction of HIA from a wider dataset.  It is 
hypothesised that by combining the physiologically relevant mixture of bile salts that 
displayed good HIA predictability with the column used in this study (R
2
pred.=81%) could 
create a mathematical model with an even higher predictive ability that could be developed 
based on a greater number of compounds in both the training and validation sets. 
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Figure 1: Chromatograms displaying the binding behaviour of meloxicam over a series of 
mobile phase concentrations with an aminopropyl column as a stationary phase. (The 
dotted line is only used for visual guidance). 
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Figure 2: Residual plot for optimal logit HIA regression model. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3: Partial regression plots of experimental logit HIA. values against log Pmw, VM and 
Sw . 
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Figure 4: Plot of experimental vs. predicted  %HIA. 
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Table 1: Experimental and predicted values for %HIA. 
Drug Expt. %HIA Pred. %HIA Reference 
Acetaminophen 95.00 94.82 (±0.04) 
(Castillo-Garit, Cañizares-
Carmenate et al. 2014) 
Acetylsalicylic 
acid 
82.00 87.00 (±0.04) 
(Castillo-Garit, Cañizares-
Carmenate et al. 2014) 
Caffeine 99.00 98.42 (±0.01) (Yan, Wang et al. 2008) 
Carbamazepine 70.00 73.53 (±0.09) 
(Varma, Sateesh et al. 
2005) 
Cimetidine* 73.50 73.60 (±0.05) 
(Veber, Johnson et al. 
2002; Yan, Wang et al. 
2008) 
Diclofenac 90.00 90.73 (±0.01) 
(Molero-Monfort, 
Escuder-Gilabert et al. 
2001) 
Fenoprofen* 85.00 93.07 (±0.06) (Hou, Wang et al. 2007) 
Fluconazole 97.50 98.29 (±0.05) 
(Castillo-Garit, Cañizares-
Carmenate et al. 2014) 
Flurbiprofen 92.00 84.68 (±0.01) (Raevsky 2004) 
Gemfibrozil 95.00 96.57 (±0.05) 
(Paixão, Gouveia et al. 
2012) 
Ibuprofen 85.00 90.25 (±0.01) 
(Paixão, Gouveia et al. 
2012) 
Indomethacin 99.00 98.22 (±0.04) (Chu 2009) 
Ketoprofen 96.00 92.94 (±0.05) 
(Castillo-Garit, Cañizares-
Carmenate et al. 2014) 
Lidocaine 95.00 96.30 (±0.02) 
(Molero-Monfort, 
Escuder-Gilabert et al. 
2001; Chu 2009) 
Lornoxicam* 100.00 88.67 (±0.06) 
(Newby, Freitas et al. 
2015) 
Meloxicam 90.00 92.40 (±0.06) 
(Castillo-Garit, Cañizares-
Carmenate et al. 2014) 
Naproxen 94.00 91.02 (±0.05) 
(Castillo-Garit, Cañizares-
Carmenate et al. 2014) 
Nicotinic acid* 94.00 100.00 (±0.01) (Yan, Wang et al. 2008) 
Phenylbutazone 98.00 98.36 (±0.01) (Hou, Wang et al. 2007) 
Piroxicam* 99.00 92.28 (±0.05) (Chu 2009) 
Salicylic acid* 99.00 75.44 (±0.08) (Raevsky 2004) 
Theophylline 98.00 98.24 (±0.01) 
(Kansy, Senner et al. 
1998) 
Terbutaline* 80.00 84.25 (±0.01) (Grès, Julian et al. 1998) 
The asterisk (*) indicates the validation compounds. 
 
 
